lysosomal enzymopathy - définition. Qu'est-ce que lysosomal enzymopathy
Diclib.com
Dictionnaire ChatGPT
Entrez un mot ou une phrase dans n'importe quelle langue 👆
Langue:

Traduction et analyse de mots par intelligence artificielle ChatGPT

Sur cette page, vous pouvez obtenir une analyse détaillée d'un mot ou d'une phrase, réalisée à l'aide de la meilleure technologie d'intelligence artificielle à ce jour:

  • comment le mot est utilisé
  • fréquence d'utilisation
  • il est utilisé plus souvent dans le discours oral ou écrit
  • options de traduction de mots
  • exemples d'utilisation (plusieurs phrases avec traduction)
  • étymologie

Qu'est-ce (qui) est lysosomal enzymopathy - définition

INHERITED METABOLIC DISORDER THAT INVOLVE AN ABNORMAL ACCUMULATION OF SUBSTANCES INSIDE THE LYSOSOME RESULTING FROM DEFECTS IN LYSOSOMAL FUNCTION
Lysosomal storage disorder; Lysosomal storage diseases; Lysosomal storage diseases, nervous system; Lysosomal disorders; Lysosomal storage disorders; Lysosomal Storage Disease; Lysosomal disorder; Lysosomal disease

Lysosomal storage disease         
Lysosomal storage diseases (LSDs; ) are a group of over 70 rare inherited metabolic disorders that result from defects in lysosomal function. Lysosomes are sacs of enzymes within cells that digest large molecules and pass the fragments on to other parts of the cell for recycling.
Lysosomal Pro-X carboxypeptidase         
CLASS OF ENZYMES
Lysosomal Pro-Xaa carboxypeptidase; EC 3.4.16.2; Angiotensinase C; Lysosomal carboxypeptidase C; Peptidylprolylamino acid carboxypeptidase; Aminoacylproline carboxypeptidase; Prolyl carboxypeptidase; Proline-specific carboxypeptidase P; Lysosomal prolylcarboxypeptidase
Lysosomal Pro-Xaa carboxypeptidase (, angiotensinase C, lysosomal carboxypeptidase C, peptidylprolylamino acid carboxypeptidase, aminoacylproline carboxypeptidase, prolyl carboxypeptidase, carboxypeptidase P, proline-specific carboxypeptidase P, PCP) is an enzyme. This enzyme catalyses the following chemical reaction
Alpha-mannosidosis         
LYSOSOMAL STORAGE DISEASE THAT HAS MATERIAL BASIS IN DEFICIENCY OF THE ALPHA-D-MANOSIDASE ENZYME RESULTING IN THE IMPAIRMENT OF CELL FUNCTION FROM A BUILD UP OF COMPLEX SUGARS DERIVED FROM GLYCOPROTEINS IN THE LYSOSOME
Lysosomal alpha-D-mannosidase deficiency; Alpha Mannosidosis
Alpha-mannosidosis is a lysosomal storage disorder, first described by Swedish physician Okerman in 1967.Malm D, Nilssen O (2008).

Wikipédia

Lysosomal storage disease

Lysosomal storage diseases (LSDs; ) are a group of over 70 rare inherited metabolic disorders that result from defects in lysosomal function. Lysosomes are sacs of enzymes within cells that digest large molecules and pass the fragments on to other parts of the cell for recycling. This process requires several critical enzymes. If one of these enzymes is defective due to a mutation, the large molecules accumulate within the cell, eventually killing it.

Lysosomal storage disorders are caused by lysosomal dysfunction usually as a consequence of deficiency of a single enzyme required for the metabolism of lipids, glycoproteins (sugar-containing proteins), or so-called mucopolysaccharides. Individually, lysosomal storage diseases occur with incidences of less than 1:100,000; however, as a group, the incidence is about 1:5,000 – 1:10,000. Most of these disorders are autosomal recessively inherited such as Niemann–Pick disease, type C, but a few are X-linked recessively inherited, such as Fabry disease and Hunter syndrome (MPS II).

The lysosome is commonly referred to as the cell's recycling center because it processes unwanted material into substances that the cell can use. Lysosomes break down this unwanted matter by enzymes, highly specialized proteins essential for survival. Lysosomal disorders are usually triggered when a particular enzyme exists in too small an amount or is missing altogether. When this happens, substances accumulate in the cell. In other words, when the lysosome does not function normally, excess products destined for breakdown and recycling are stored in the cell.

Like other genetic disorders, individuals inherit lysosomal storage diseases from their parents. Although each disorder results from different gene mutations that translate into a deficiency in enzyme activity, they all share a common biochemical characteristic – all lysosomal disorders originate from an abnormal accumulation of substances inside the lysosome.

Lysosomal storage diseases affect mostly children and they often die at a young age, many within a few months or years of birth.